FCGBX | FWCBX | FCGBX / FWCBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 4 years | - |
Gain YTD | 0.096 | 7.535 | 1% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 292M | 105B | 0% |
Annual Yield % from dividends | 2.95 | 3.54 | 83% |
Returns for 1 year | 0.91 | 8.57 | 11% |
Returns for 3 years | -2.51 | 11.73 | -21% |
Returns for 5 years | -5.13 | N/A | - |
Returns for 10 years | -3.92 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 32.60 | 0.46 | +1.43% |
Eventide Healthcare & Life Sciences A | |||
GSVTX | 15.86 | 0.18 | +1.15% |
Goldman Sachs Large Cap Value Inv | |||
FCDIX | 37.57 | 0.22 | +0.59% |
Fidelity Advisor Stock Selector Sm Cp I | |||
NUIAX | 27.96 | -0.10 | -0.36% |
Nuveen International Dividend Growth A | |||
JHJAX | 22.95 | -1.97 | -7.92% |
JHancock ESG Large Cap Core A |